The nation of Zimbabwe has rejected a substantial US healthcare agreement worth 367 million US dollars (£272m) over five years because of Washington's request for confidential biological samples.
This rejection was revealed following a internal memorandum dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government representative has since clarified that the United States was requesting genetic material for scientific study and commercial purposes while was unwilling to share the benefits from any future medical innovations.
"We must now begin the difficult and regrettable process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for more dialogue to find a agreement suitable to all parties so the country's vital HIV programme can continue.
Wider Implications
This rejection comes after a comparable situation in Kenya, where a high court suspended a related deal with the US following concerns were filed about the safety of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump stated its expenditure was "wasteful" and his administration was seeking government-to-government agreements to enhance openness and accountability.
Based on statements, 16 African countries have so far signed these new health pacts, representing over $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," his statement read.
"Put simply, our nation would provide the raw materials for scientific discovery with no certainty that the end products would be accessible to our population if a new disease outbreak emerge."
Sovereignty and International Frameworks
He also noted that the American exit from the global health body and its push of one-on-one deals were disrupting structures already established through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.
"This system is designed to guarantee that when a nation contributes its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome further dialogue with our US partners on how future co-operation could be structured in a manner that honours the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but suggested that talks need to persist considering much of the nation's Aids initiatives depended on external financing.
"In cases where specific concerns exist, including those involving data governance or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," it said.
The situation emphasises the complex challenges between accepting much-needed international aid and protecting local interests in an increasingly interconnected world.